These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9543090)

  • 1. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit.
    Bocan TM; Rosebury WS; Mueller SB; Kuchera S; Welch K; Daugherty A; Cornicelli JA
    Atherosclerosis; 1998 Feb; 136(2):203-16. PubMed ID: 9543090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation.
    Bocan TM; Mueller SB; Mazur MJ; Uhlendorf PD; Brown EQ; Kieft KA
    Atherosclerosis; 1993 Aug; 102(1):9-22. PubMed ID: 8257456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.
    Bocan TM; Mueller SB; Uhlendorf PD; Newton RS; Krause BR
    Arterioscler Thromb; 1991; 11(6):1830-43. PubMed ID: 1931885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits.
    Bocan TM; Mueller SB; Brown EQ; Uhlendorf PD; Mazur MJ; Newton RS
    Exp Mol Pathol; 1992 Aug; 57(1):70-83. PubMed ID: 1397193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary and mechanically induced rabbit iliac-femoral atherosclerotic lesions: a chemical and morphologic evaluation.
    Bocan TM; Mueller SB; Uhlendorf PD; Ferguson E; Newton RS
    Exp Mol Pathol; 1991 Jun; 54(3):201-77. PubMed ID: 2060606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties.
    Sendobry SM; Cornicelli JA; Welch K; Bocan T; Tait B; Trivedi BK; Colbry N; Dyer RD; Feinmark SJ; Daugherty A
    Br J Pharmacol; 1997 Apr; 120(7):1199-206. PubMed ID: 9105693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation.
    Bocan TM; Mazur MJ; Mueller SB; Brown EQ; Sliskovic DR; O'Brien PM; Creswell MW; Lee H; Uhlendorf PD; Roth BD
    Atherosclerosis; 1994 Nov; 111(1):127-42. PubMed ID: 7840808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
    Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
    Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression.
    Bocan TM; Krause BR; Rosebury WS; Lu X; Dagle C; Bak Mueller S; Auerbach B; Sliskovic DR
    Atherosclerosis; 2001 Jul; 157(1):97-105. PubMed ID: 11427208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit.
    Bocan TM; Mueller SB; Brown EQ; Lee P; Bocan MJ; Rea T; Pape ME
    Atherosclerosis; 1998 Jul; 139(1):21-30. PubMed ID: 9699888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
    Shen J; Herderick E; Cornhill JF; Zsigmond E; Kim HS; Kühn H; Guevara NV; Chan L
    J Clin Invest; 1996 Nov; 98(10):2201-8. PubMed ID: 8941635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Lipoxygenase in monocytes emerges as a therapeutic target for intimal hyperplasia in a murine wire-injured femoral artery.
    Baek SE; Jang MA; Lee SJ; Park SY; Bae SS; Kim CD
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2210-2219. PubMed ID: 28645655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions.
    Vijayagopal P; Srinivasan SR; Xu JH; Dalferes ER; Radhakrishnamurthy B; Berenson GS
    J Clin Invest; 1993 Mar; 91(3):1011-8. PubMed ID: 8450030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
    Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.
    Rival Y; Junquéro D; Bruniquel F; N'Guyen X; Fauré P; Pomiès JP; Degryse AD; Delhon A
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):181-91. PubMed ID: 11791003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study.
    Ohtsuki K; Hayase M; Akashi K; Kopiwoda S; Strauss HW
    Circulation; 2001 Jul; 104(2):203-8. PubMed ID: 11447087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and physiochemical comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand White and Watanabe Heritable Hyperlipidemic rabbits.
    Nolte CJ; Tercyak AM; Wu HM; Small DM
    Lab Invest; 1990 Feb; 62(2):213-22. PubMed ID: 2304334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.